Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA

doi:10.3748/wjg.v10.i3.427

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8070)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

737

HTML

6396

Figures (1-2)

428

Tables (1-4)

509

Sum=8070

Feb 1, 2004 (publication date) through Oct 31, 2025

Times Cited of This Article

Times Cited (133)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Brief Reports

World J Gastroenterol. Feb 1, 2004; 10(3): 427-432
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.427

Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: In comparison with CEA

Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Min Lu, Lin Wang, Quan-Ru He

Xing-Lei Qin, Zuo-Ren Wang, Jing-Sen Shi, Lin Wang, Department of Hepatobiliary Surgery, First Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China

Min Lu, Quan-Ru He, Luoyang Central Hospital, Luoyang 471009, Henan Province, China

Author contributions: All authors contributed equally to the work.

Correspondence to: Dr. Xing-Lei Qin, M.D., Department of Hepatobiliary Surgery, First Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China. qinxinglei@yahoo.com.cn

Telephone: +86-29-5274739 Fax: +86-29-5269313

Received: June 5, 2003
Revised: July 15, 2003
Accepted: July 24, 2003
Published online: February 1, 2004

Core Tip